U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Dacarbazine Injection
Status: Currently in Shortage
»Date first posted: 10/20/2021
»Therapeutic Categories: Oncology

Expand all

Fresenius Kabi USA, LLC (Revised 03/10/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial, Single Dose Amber Vial (NDC 63323-127-10) Available Available
200 mg per vial, Single Dose Amber Vial (NDC 63323-128-20) Backordered. Next release March 2023. Manufacturing delay

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 10/13/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg/vial (NDC 0143-9245-10) Inventory is currently available. Additional lots will be scheduled for manufacturing. Product will be made available as it is released. Demand increase for the drug

Teva Pharmaceuticals (Revised 01/09/2023)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg 10x20mL (NDC 00703-5075-03) Unavailable Recovery TBD Demand increase for the drug
200 mg 1x20mL (NDC 00703-5075-01) Unavailable Recovery TBD Demand increase for the drug
Back to Top